Search Results 1171-1180 of 16293 for Nucleus

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  2. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  3. Neuroblastoma - Doctors and departments - Mayo Clinic

    Learn more about the symptoms, diagnosis and treatment of neuroblastoma, one of the most common cancers of childhood.

  4. Adnexal tumors and masses - Doctors and departments - Mayo Clinic

    Learn about symptoms, diagnosis and treatment of these growths that occur in and around the ovaries and fallopian tubes.

  5. Neuroblastoma - Doctors and departments - Mayo Clinic

    Learn more about the symptoms, diagnosis and treatment of neuroblastoma, one of the most common cancers of childhood.

  6. Adrenal cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that begins in the adrenal glands. Find out about symptoms, diagnosis and treatment.

  7. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  9. Adrenal cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that begins in the adrenal glands. Find out about symptoms, diagnosis and treatment.

  10. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

    About this study. The purpose of this trial is to evaluate the effectiveness, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks ...